Ciano-, Nitrilo-

<p>Applications 1-Cyanotetraline is used in the synthesis of aldose reductase inhibitors. Also reductase enzymes are believed to catalyze the formation of sorbitol from glucose leading to the chronic complications of diabetes mellitus. It is also used in the synthesis of baclofen analogs, potent GABAB agonists.<br>References Sarges, R. et al.: J. Med. Chem., 31, 230 (1988); Mann, A. et al.: J. Med. Chem., 34, 1307 (1991);<br></p>

<p>Applications 3-(1-Cyanoethyl)benzoic Acid is an intermediate for the synthetic preparation of various pharmaceutical compounds. 3-(1-Cyanoethyl)benzoic Acid was used in studies examining the enantioselectivity of nitrile hydratases.<br>References Rzeznicka, K., et al.: App. Microbiol. Biotechnol., 85, 1417 (2010); Van Pelt. S., et al.: Org. Biomole. Chem., 9, 3011 (2011);<br></p>

<p>Applications Pyrimethamine intermediate.<br>References Takayama, K., et al.: Antimicrob. Agents Chemother., 33, 1493 (1989), Robson, C., et al.: J. Med. Chem., 40, 3040 (1997), Horton, J., et al.: J. Mol. Biol., 353, 334 (2005), Horton, J., et al.: J. Mol. Biol., 353, 334 (2005), Janin, Y., et al.: Bioorg. Med. Chem., 15, 2479 (2007),<br></p>

<p>Stability Light Sensitive<br>Applications Dibromoacetonitrile is a carcinogenic nitrogenous disinfection byproduct. Dibromoacetonitrile in drinking water was linked to oral cavity cancer in rats and forestomach cancer in mice. In addition, Dibromoacetonitrile may cause oxidative damage in rat brain.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Guo, Z., et al.: Chem. Eng. J. 306, 1180 (2016); Krasner, S. W., et al.: Environ. Sci. Technol. 50, 9583 (2016); Natl Toxicol Program Tech Rep Ser. 544, 1 (2010); Klattisaksiri, P., et al.: Water Res 98, 160 (2016); Sayed, R. H., et al.: Environ Toxicol Pharmacol. 34, 849 (2012)<br></p>

<p>Applications A useful synthetic intermediate.<br></p>

<p>S05035 - 3-Cyanopropyltrimethoxysilane</p>